It has also been suggested that male-specific susceptibility to hepatocellular carcinoma is due to female protection via estrogen-mediated inhibition of IL-6 expression, as well as direct inhibition of STAT3 via estrogen-mediated expression of the tyrosine phosphatase PTPRO [31]. The gene discussed is IL6; the disease is hepatocellular carcinoma.